直播預告 | 生物技術轉移：從MIT實驗室到新公司

直播時間：9月7日上午8:00-9:00

直播平臺：上海技術交易所視頻號

特邀講師：[美]Lita Nelsen

分享內容

在生物科技行業，很多生物企業都是在大學研究中發展出來，專利權歸大學所有，技術的使用權力也是通過大學的授權。

本次研討會將討論麻省理工學院如何通過其技術許可辦公室管理專利申請和許可，以及如何用更多的舉措，來鼓勵教師和學生的創業精神，從而幫助數百家新的生物技術公司從麻省理工學院和其附屬機構懷特黑德研究所，分離出來，創造出更多優秀的企業。

講師介紹

Lita Nelsen

擔任麻省理工學院技術許可辦公室主任25年後退休，現在是幾家新興生物技術公司的顧問或董事會成員，也是麻省理工學院Sandbox學生創業項目的導師、早期風險投資公司GoodGrowth Capital的顧問，以及香港大學技術授權講師。

Content

Discover the driving force behind the dynamic biotech landscape at our seminar. Unveiling the blueprint for success, we delve into the pivotal role of university research in birthing groundbreaking biotech ventures. With a significant proportion of emerging biotech companies tracing their roots back to cutting-edge university discoveries fueled by Federal funding, the seminar illuminates the transformative journey of ideas from academia to the marketplace.

The majority of new biotech companies originate with new discoveries and inventions from university research, most of which was sponsored by Federal funding. Patents from such research are owned by the universities, and rights to them are given to new startups via licensed granted by the university.

This seminar discusses how MIT manages patent filings and licensing through its Technology Licensing Office, and encourages entrepreneurship by faculty and students through its many “Innovation” initiatives. Hundreds of new biotech companies have spun out of MIT and its Whitehead Institute affiliate. Some of the more famous local companies include Alnylam, BluebirdBio, Momenta, and Ginko Bioworks.

Lecturer

Lita Nelsen retired after over 25 years as Director of MIT’s Technology Licensing Office. She is now a consultant or board member to several new biotech companies and a mentor in MIT’s Sandbox student entrepreneurship program and an advisor to GoodGrowth Capital, an early stage venture capital company. She is also a lecturer in technology licensing for Hong Kong University.

關注“全球跨境技術貿易中心”

瞭解更多訊息

上 技 國 際

-STEX INTERNATIONAL-